Fasting protects mice from lethal DNA damage by promoting small intestinal epithelial stem cell survival
Kelsey L Tinkum, Kristina M Stemler, Lynn S White, Andrew J Loza, Sabrina Jeter-Jones, Basia M Michalski, Catherine Kuzmicki, Robert Pless, Thaddeus S Stappenbeck, David Piwnica-Worms, Helen Piwnica-Worms, Kelsey L Tinkum, Kristina M Stemler, Lynn S White, Andrew J Loza, Sabrina Jeter-Jones, Basia M Michalski, Catherine Kuzmicki, Robert Pless, Thaddeus S Stappenbeck, David Piwnica-Worms, Helen Piwnica-Worms
Abstract
Short-term fasting protects mice from lethal doses of chemotherapy through undetermined mechanisms. Herein, we demonstrate that fasting preserves small intestinal (SI) architecture by maintaining SI stem cell viability and SI barrier function following exposure to high-dose etoposide. Nearly all SI stem cells were lost in fed mice, whereas fasting promoted sufficient SI stem cell survival to preserve SI integrity after etoposide treatment. Lineage tracing demonstrated that multiple SI stem cell populations, marked by Lgr5, Bmi1, or HopX expression, contributed to fasting-induced survival. DNA repair and DNA damage response genes were elevated in SI stem/progenitor cells of fasted etoposide-treated mice, which importantly correlated with faster resolution of DNA double-strand breaks and less apoptosis. Thus, fasting preserved SI stem cell viability as well as SI architecture and barrier function suggesting that fasting may reduce host toxicity in patients undergoing dose intensive chemotherapy.
Keywords: DNA damage; chemotherapy; fasting; stem cells.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Source: PubMed